CD19-directed Chimeric Antigen Receptor

All categories
Name
CD19-directed Chimeric Antigen Receptor
Accession Number
DBCAT005468
Description

Not Available

Drugs
DrugDrug Description
TisagenlecleucelA CAR T cell therapy for relapsed or refractory large B-cell lymphoma and diffuse large B-cell lymphoma.
Axicabtagene ciloleucelA CAR T-cell therapy used to treat adults with large B-cell lymphomas and follicular lymphoma.
Drugs & Drug Targets
DrugTargetType
TisagenlecleucelB-lymphocyte antigen CD19target
Axicabtagene ciloleucelB-lymphocyte antigen CD19target